Literature DB >> 25293775

Cell-type-specific transcriptional regulation of PIGM underpins the divergent hematologic phenotype in inherited GPl deficiency.

Joana R Costa1, Valentina S Caputo2, Kalliopi Makarona2, D Mark Layton2, Irene A G Roberts3, Antonio M Almeida4, Anastasios Karadimitris2.   

Abstract

A rare point mutation in the core promoter -270GC-rich box of PIGM, a housekeeping gene, disrupts binding of the generic transcription factor (TF) Sp1 and causes inherited glycosylphosphatidylinositol (GPI) deficiency (IGD). We show that whereas PIGM messenger RNA levels and surface GPI expression in IGD B cells are low, GPI expression is near normal in IGD erythroid cells. This divergent phenotype results from differential promoter chromatin accessibility and binding of Sp1. Specifically, whereas PIGM transcription in B cells is dependent on Sp1 binding to the -270GC-rich box and is associated with lower promoter accessibility, in erythroid cells, Sp1 activates PIGM transcription by binding upstream of (but not to) the -270GC-rich box. These findings explain intact PIGM transcription in IGD erythroid cells and the lack of clinically significant intravascular hemolysis in patients with IGD. Furthermore, they provide novel insights into tissue-specific transcriptional control of a housekeeping gene by a generic TF.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25293775      PMCID: PMC4231422          DOI: 10.1182/blood-2014-09-598813

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  A global role for KLF1 in erythropoiesis revealed by ChIP-seq in primary erythroid cells.

Authors:  Michael R Tallack; Tom Whitington; Wai Shan Yuen; Elanor N Wainwright; Janelle R Keys; Brooke B Gardiner; Ehsan Nourbakhsh; Nicole Cloonan; Sean M Grimmond; Timothy L Bailey; Andrew C Perkins
Journal:  Genome Res       Date:  2010-05-27       Impact factor: 9.043

2.  Targeted therapy for inherited GPI deficiency.

Authors:  Antonio M Almeida; Yoshiko Murakami; Alastair Baker; Yusuke Maeda; Irene A G Roberts; Taroh Kinoshita; D Mark Layton; Anastasios Karadimitris
Journal:  N Engl J Med       Date:  2007-04-19       Impact factor: 91.245

3.  Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome.

Authors:  Bobby G Ng; Karl Hackmann; Melanie A Jones; Alexey M Eroshkin; Ping He; Roy Wiliams; Shruti Bhide; Vincent Cantagrel; Joseph G Gleeson; Amy S Paller; Rhonda E Schnur; Sigrid Tinschert; Janice Zunich; Madhuri R Hegde; Hudson H Freeze
Journal:  Am J Hum Genet       Date:  2012-03-22       Impact factor: 11.025

4.  Isolation, genomic structure, and expression of human erythroid Krüppel-like factor (EKLF).

Authors:  J J Bieker
Journal:  DNA Cell Biol       Date:  1996-05       Impact factor: 3.311

5.  Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency.

Authors:  Antonio M Almeida; Yoshiko Murakami; D Mark Layton; Peter Hillmen; Gabrielle S Sellick; Yusuke Maeda; Stephen Richards; Scott Patterson; Ioannis Kotsianidis; Luigina Mollica; Dorothy H Crawford; Alastair Baker; Michael Ferguson; Irene Roberts; Richard Houlston; Taroh Kinoshita; Anastasios Karadimitris
Journal:  Nat Med       Date:  2006-06-11       Impact factor: 53.440

6.  Mechanism for release of alkaline phosphatase caused by glycosylphosphatidylinositol deficiency in patients with hyperphosphatasia mental retardation syndrome.

Authors:  Yoshiko Murakami; Noriyuki Kanzawa; Kazunobu Saito; Peter M Krawitz; Stefan Mundlos; Peter N Robinson; Anastasios Karadimitris; Yusuke Maeda; Taroh Kinoshita
Journal:  J Biol Chem       Date:  2012-01-06       Impact factor: 5.157

7.  Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome.

Authors:  Peter M Krawitz; Michal R Schweiger; Christian Rödelsperger; Carlo Marcelis; Uwe Kölsch; Christian Meisel; Friederike Stephani; Taroh Kinoshita; Yoshiko Murakami; Sebastian Bauer; Melanie Isau; Axel Fischer; Andreas Dahl; Martin Kerick; Jochen Hecht; Sebastian Köhler; Marten Jäger; Johannes Grünhagen; Birgit Jonske de Condor; Sandra Doelken; Han G Brunner; Peter Meinecke; Eberhard Passarge; Miles D Thompson; David E Cole; Denise Horn; Tony Roscioli; Stefan Mundlos; Peter N Robinson
Journal:  Nat Genet       Date:  2010-08-29       Impact factor: 38.330

8.  Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria.

Authors:  J Takeda; T Miyata; K Kawagoe; Y Iida; Y Endo; T Fujita; M Takahashi; T Kitani; T Kinoshita
Journal:  Cell       Date:  1993-05-21       Impact factor: 41.582

Review 9.  Sp1- and Krüppel-like transcription factors.

Authors:  Joanna Kaczynski; Tiffany Cook; Raul Urrutia
Journal:  Genome Biol       Date:  2003-02-03       Impact factor: 13.583

10.  Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene.

Authors:  M Bessler; P J Mason; P Hillmen; T Miyata; N Yamada; J Takeda; L Luzzatto; T Kinoshita
Journal:  EMBO J       Date:  1994-01-01       Impact factor: 11.598

View more
  1 in total

Review 1.  CDG Therapies: From Bench to Bedside.

Authors:  Sandra Brasil; Carlota Pascoal; Rita Francisco; Dorinda Marques-da-Silva; Giuseppina Andreotti; Paula A Videira; Eva Morava; Jaak Jaeken; Vanessa Dos Reis Ferreira
Journal:  Int J Mol Sci       Date:  2018-04-27       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.